| | | |   | | | | By Ed Silverman CRIS BOURONCLE/AFP/Getty Images "The lower the price, the more you can scale up testing,” said Stijn Deborggraeve of Doctors Without Borders. Read More | | By Rachel Cohrs Alex Wong/Getty Images Democrats’ new drug pricing reforms have been shaped by legislative haggling, Senate rules, and years of policy debates. Read More | | By Jason Mast Mel Evans/AP The pharma giant announced a deal to develop vaccines and therapies with Orna Therapeutics, a startup with a slightly different take on mRNA technology. Read More | | Sponsor content by STAT+ Biopharma breakthroughs, business, and policy analysis — at your fingertips Enjoy daily, market-moving analysis of the biotech, pharma, and life sciences industries with STAT Plus. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. Don't be the last to know. Subscribe today to start reading. | | By Justin Norden Adobe The investment community needs to raise the bar and demand transparent and verifiable evidence from digital health companies. Read More | |
No comments